Kezar Life Sciences buy BiotechBee
Start price
07.09.22
/
80%
€9.70
Target price
31.12.24
€20.00
Performance (%)
-76.29%
End price
05.05.23
€2.30
Summary
This prediction ended on 05.05.23 with a price of €2.30. Massive losses of -76.29% were the result for the BUY prediction by BiotechBee. BiotechBee has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Kezar Life Sciences | - | - | - | - |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % | 53,70 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % | 76,70 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % | 60,79 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % | 62,81 % |
According to BiotechBee what are the pros and cons of Kezar Life Sciences for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Kezar Life Sciences diskutieren
Buy mit Kursziel 20,0